Back to search

Article

Dual Inhibition of CDK4/6 and mTORC1 Establishes a Preclinical Strategy for Translocation Renal Cell Carcinoma

2025-07-17

Abstract excerpt

<h4>Purpose</h4> Translocation renal cell carcinoma (tRCC) is a rare and aggressive subtype of kidney cancer driven by an oncogenic fusion involving a transcription factor in the MiT/TFE gene family, most commonly TFE3 . Treatment of tRCC currently lacks a clear standard of care, underscoring the pressing need to nominate new therapeutic targets with mechanistic rationale in this cancer. <h4>Experimental Desig...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1517236-7d2e-58a0-8a93-ee5f41ddc5cd
DOI
10.1101/2025.07.11.663903
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dual Inhibition of CDK4/6 and mTORC1 Establishes a Preclinical Strategy for Translocation Renal Cell CarcinomaDOI 10.1101/2025.07.11.663903
Select a neighboring publication to make it the new centre.